Articles: FDA Approves High Dose Exelon Patch

FDA Approves High Dose Exelon Patch:

http://www.prnewswire.com/news-releases/higher-dose-of-novartis-drug-exelon-patch-approved-by-fda-for-patients-with-mild-to-moderate-alzheimers-disease-168422476.html